IngenOx Therapeutics, the Oxford biopharma company focused on developing novel cancer therapeutics, provided today a company update on its board reshuffle. In the revised board, Patrick Soon-Shiong, M.D. joins as Chairman. Leonard S. Sender, M.D. and Sandeep “Bobby” Reddy, M.D.…
Oxford, UK – 07 Dec 2023 Download this Press Release as a PDF IngenOx Therapeutics, an Oxford-based biopharmaceutical company, announced that its Chief Medical Officer, Prof. David Kerr had published a review on the use of diagnostic biomarkers to personalise…
Oxford, UK – 6 October 2023 Download this Press Release as a PDF IngenOx Therapeutics, the Oxford-based biopharmaceutical company announced today that it had received separate grants of applications from the Chinese (CNIPA); and European Patent Office for compounds and…